Gilead Sciences Inc
said on Tuesday it was in discussions with chemical and drug
manufacturers to produce its antiviral drug remdesivir for Europe, Asia
and the developing world through at least 2022.
The drugmaker last week received the U.S. Food and Drug
Administration’s emergency use authorisation for using remdesivir as a
treatment against COVID-19, the respiratory illness caused by the new
coronavirus.
Gilead also said on Tuesday it was negotiating long-term voluntary
licenses with several generic drugmakers in India and Pakistan to
produce remdesivir for developing countries.
https://www.marketscreener.com/GILEAD-SCIENCES-4876/news/Gilead-Sciences-in-talks-to-expand-global-supply-of-COVID-19-drug-remdesivir-30545153/
Tuesday, May 5, 2020
CVS Health Q1 2020 Earnings Preview
CVS Health (NYSE:CVS) is scheduled to announce Q1 earnings results on Wednesday, May 6th, before market open.
The consensus EPS Estimate is $1.63 (+0.6% Y/Y) and the consensus Revenue Estimate is $64.14B (+4.0% Y/Y).
Over the last 2 years, CVS has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 7 upward revisions and 10 downward. Revenue estimates have seen 8 upward revisions and 3 downward.
https://seekingalpha.com/news/3569210-cvs-health-q1-2020-earnings-preview
UK’s obese residents may be forced to stay home once lockdown ends
Obese Britons may be forced to work from home even as others return after the coronavirus lockdown, according to reports.
Leaked government documents show that the obese are being treated as “vulnerable” people — along with those over 70 and pregnant women — who will be told to stay home even when the general lockdown is lifted, the Sun said.
Companies may even have to find new roles for the workers who need to stay home, the report says.
Almost a third of adults in England are clinically obese — one of the highest rates in the Western world — and the stringent rules could be enforced for up to a year, the paper says.
Health Secretary Matt Hancock spoke Monday of the possible relationship between obesity and becoming critically ill if infected by the coronavirus.
“Emerging data from around the world suggests there could possibly be a relationship between obesity and the impact of COVID-19 on individuals,” he said, according to the report.
“It’s too early to say if obesity in itself is a factor or conditions associated with it — or there is not enough data yet to rule it out — so we need to approach any assumptions with caution.”
A study of coronavirus patients in New York state’s largest hospital system found 42 percent of them were obese.
https://nypost.com/2020/05/05/obese-brits-may-be-forced-to-stay-home-after-lockdown-lifted/
Leaked government documents show that the obese are being treated as “vulnerable” people — along with those over 70 and pregnant women — who will be told to stay home even when the general lockdown is lifted, the Sun said.
Companies may even have to find new roles for the workers who need to stay home, the report says.
Almost a third of adults in England are clinically obese — one of the highest rates in the Western world — and the stringent rules could be enforced for up to a year, the paper says.
Health Secretary Matt Hancock spoke Monday of the possible relationship between obesity and becoming critically ill if infected by the coronavirus.
“Emerging data from around the world suggests there could possibly be a relationship between obesity and the impact of COVID-19 on individuals,” he said, according to the report.
“It’s too early to say if obesity in itself is a factor or conditions associated with it — or there is not enough data yet to rule it out — so we need to approach any assumptions with caution.”
A study of coronavirus patients in New York state’s largest hospital system found 42 percent of them were obese.
https://nypost.com/2020/05/05/obese-brits-may-be-forced-to-stay-home-after-lockdown-lifted/
Jazz Pharma down 9% after hours on Q1 miss, guidance cut
Jazz Pharmaceuticals (NASDAQ:JAZZ) Q1 results:
Revenues: $534.7M (+5.2%); product sales: $530.2M (+5.3%).
Xyrem sales: $407.9M (+10.8%); Defitelio/defibrotide: $47.4M (+14.2%); Erwinaze: $37.7M (-38.1%).
Net loss: ($157.8M) (-285.2%); non-GAAP net
income: $25.8M (-84.3%); loss/share: ($2.82) (-291.8%); non-GAAP EPS:
$0.45 (-84.1%).
~1.1M ordinary shares repurchased at an average price of $122.91.
2020 guidance: Revenues: $2,120M –
2,260M from $2,320M – 2,400M; product sales: $2,105M – 2,240M from
$2,305M – 2,375M; sleep/neuroscience sales: $1,650M – 1,740M from
$1,740M – 1,810M; hematology/oncology sales: $420M – 510M from $500M –
580M.
Shares down 9% after hours.
https://seekingalpha.com/news/3569640-jazz-pharma-down-9-after-hours-on-q1-miss-guidance-cutMacroGenics EPS beats by $0.11, beats on revenue
MacroGenics (NASDAQ:MGNX): Q1 GAAP EPS of -$0.91 beats by $0.11.
Revenue of $13.68M (+41.6% Y/Y) beats by $4.2M.
https://seekingalpha.com/news/3569690-macrogenics-eps-beats-0_11-beats-on-revenueSweden: Covid-19 likely in country as early as November 2019 from Wuhan
A top Swedish health official says it’s likely there were imported
coronavirus cases as early as last year in the nation, according to a
report.
Anders Tegnell, chief epidemiologist at Sweden’s Public Health Agency, said that he believes the Scandinavian country will ultimately find that it had cases far back as November 2019, the Telegraph reported.
“I think you could find individual cases among travelers to Wuhan who were there back in November and December last year,” he told Sweden’s TT news agency, according to the outlet. “That doesn’t sound strange at all, but more completely to be expected.”
His comments come in response to the revelation that a patient in France was infected with COVID-19 back in December — a month before the contagion was thought to have reached Europe.
Doctors retroactively tested the samples from when the man was admitted to a hospital near Paris on Dec. 27 with a cough, headache and fever.
https://nypost.com/2020/05/05/sweden-says-coronavirus-likely-in-country-as-early-as-november-2019/
Anders Tegnell, chief epidemiologist at Sweden’s Public Health Agency, said that he believes the Scandinavian country will ultimately find that it had cases far back as November 2019, the Telegraph reported.
“I think you could find individual cases among travelers to Wuhan who were there back in November and December last year,” he told Sweden’s TT news agency, according to the outlet. “That doesn’t sound strange at all, but more completely to be expected.”
His comments come in response to the revelation that a patient in France was infected with COVID-19 back in December — a month before the contagion was thought to have reached Europe.
Doctors retroactively tested the samples from when the man was admitted to a hospital near Paris on Dec. 27 with a cough, headache and fever.
https://nypost.com/2020/05/05/sweden-says-coronavirus-likely-in-country-as-early-as-november-2019/
PerkinElmer EPS beats by $0.15, beats on revenue
Revenue of $652.59M (+0.6% Y/Y) beats by $18.13M.
https://seekingalpha.com/news/3569550-perkinelmer-eps-beats-0_15-beats-on-revenue
Subscribe to:
Posts (Atom)